GE Healthcare's Total Molecular Imaging Solutions Enable Precision Health and Theranostics for Personalized Prostate Cancer Care
At the Society of Nuclear Medicine & Molecular Imaging (SNMMI) 2022 Annual Meeting, GE Healthcare showcases cutting-edge solutions spanning the care continuum and enabling theranostics in prostate cancer